Prospect: information for the user
Votrient 200mg film-coated tablets
Votrient 400mg film-coated tablets
pazopanib
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1.What is Votrient and for what it is used
2.What you need to know before starting to take Votrient
3.How to take Votrient
4.Possible adverse effects
5.Storage of Votrient
6.Contents of the package and additional information
Votrient is a type of medication calledprotein kinase inhibitor. It works by preventing the activity of proteins involved in the growth and spread of cancer cells.
Votrient is used in adults for the treatment of:
some types of soft tissue sarcoma, which is a type of cancer that affects the body's connective tissue. It can appear in muscles, blood vessels, fat tissue, or other tissues that connect, surround, and protect organs.
Do not take Votrient
Consult your doctorif you think you may be allergic.
Warnings and precautions
Consult your doctor before starting Votrient:
Consult your doctorif you think you may have any of these problems. Your doctor will decide if Votrient is suitable for you. You may needadditional teststo check that your kidneys, heart and liver are working properly.
High blood pressure and Votrient
Votrient may increase your blood pressure. Your doctor will check your blood pressure before you start taking Votrient and while you are taking it. If you have high blood pressure, you will be given medication to help lower it.
If you are to undergo surgery
Your doctor will tell you to stop taking Votrient at least 7days before your surgery as this may affect wound healing. Your treatment will be resumed when your wounds have healed properly.
Conditions that require attention
Votrient may make other conditions worse or cause serious side effects. You should be aware of certain symptoms while taking Votrient to reduce the risk of any problems. Seesection4.
Children and adolescents
Votrient is not recommended for people under 18years of age. Its effects in this age group are not yet known. Additionally, it should not be used in children under 2years of age due to safety concerns.
Other medicines and Votrient
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine. This includes herbal remedies and over-the-counter medicines.
Some medicines may affect the way Votrient works or increase the risk of side effects. Votrient may also affect the way other medicines work. These include:
Inform your doctoror pharmacist if you are taking any of these medicines.
Taking Votrient with food and drink
Do not take Votrient with food, as this affects the absorption of the medicine. Take it at least two hours after a meal or one hour before a meal (see section3).
Do not drink grapefruit juicewhile taking Votrient, as this may increase the risk of side effects.
Pregnancy, breastfeeding and fertility
Votrient is not recommended if you are pregnant.The effects of Votrient during pregnancy are not yet known.
Do not breastfeed while taking Votrient. The components of Votrient are not yet known to pass into breast milk. Inform your doctor of this.
Male patients(including those who have undergone vasectomy) who have partners who are pregnant or may become pregnant (including those using other methods of contraception) should use condoms during sexual intercourse, while taking Votrient and for at least 2weeks after the last dose.
Fertility may be affectedby treatment with Votrient. Consult your doctor about this.
Driving and operating machinery
Votrient may cause side effects that may affect your ability to drive or operate machinery.
Votrient contains sodium
This medicine contains less than 1mmol of sodium (23mg) per coated tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
How much to take
Usual doseis 800mg taken once a day. The dose can be taken as 2tablets of 400mg or as 4tablets of 200mg. The 800mg once a day dose is the maximum daily dose. Your doctor may need to reduce your dose if you experience side effects.
When to take it
Do not take Votrient with food.Take it at least two hours after a meal or one hour before a meal. For example, you can take it two hours after breakfast or one hour before a meal. Take Votrient at the same time every day.
Swallow the tablets whole with water, and one after the other. Do not break or crush the tablets as this affects how the medication is absorbed and may increase the risk of side effects.
If you take more Votrient than you should
If you take more tablets than you should,ask your doctor or pharmacist for advice.If possible, show them the packaging or this leaflet.
If you forget to take Votrient
Do not take a double dose to make up for the missed doses. Simply take your next dose at the usual time.
Do not stop taking Votrient
Take Votrient for the time recommended by your doctor. Do not stop taking the medication unless your doctor advises you to.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Possible serious side effects
Brain inflammation(posterior reversible encephalopathy syndrome).
In rare cases, Votrient can cause brain inflammation, which can put your life at risk. Among the symptoms are:
Stop taking Votrient and seek medical attention immediatelyif you experience any of these symptoms or if you have a headache accompanied by any of these symptoms.
Hypertensive crises(sudden and severe increase in blood pressure).
Votrient can cause a sudden and severe increase in blood pressure in some cases. This is known as a hypertensive crisis. Your doctor will monitor your blood pressure while you are taking Votrient. The signs and symptoms of a hypertensive crisis may include:
Stop taking Votrient and seek medical attention immediatelyif you experience a hypertensive crisis.
Heart problems
The risk of these problems may be higher in people who have a heart problem or who are taking other medicines. While you are taking Votrient, your doctor will monitor you for any heart problems.
Cardiac alteration/heart failure, cardiac arrest
Votrient may affect the way your heart pumps blood or may increase the likelihood of a cardiac arrest.
The signs and symptoms include:
Seek medical attention immediatelyif you experience any of these symptoms.
Changes in heart rhythm (prolongation of the QT interval)
Votrient may affect your heart rhythm, which in some people may trigger a potentially life-threatening heart condition known as torsade de pointes. This can cause an acceleration of your heart rhythm, which may lead to loss of consciousness.
Inform your doctorif you notice anyunusual change in your heartbeat, such as beats that are too fast or too slow.
Stroke
Votrient may increase the likelihood of a stroke. The signs and symptoms of a stroke may include:
Seek medical attention immediatelyif you experience any of these symptoms.
Bleeding
Votrient may cause severe bleeding in the digestive tract (in the stomach, esophagus, rectum, or intestines), or in the lungs, kidneys, mouth, vagina, or brain, although this is rare. Among the symptoms are:
Seek medical attention immediatelyif you experience any of these symptoms.
Perforation and fistula
Votrient may cause a perforation in the stomach or the wall of the intestine or the formation of an abnormal connection between two parts of the digestive tract (a fistula). The signs and symptoms may include:
Seek medical attention immediatelyif you experience any of these symptoms.
Liver problems
Votrient may cause liver problems that can become serious conditions such as liver failure or hepatic failure, which can be fatal. Your doctor will monitor your liver enzymes while you are taking Votrient. The signs that your liver may not be functioning correctly may include:
-yellowing of the skin or the white part of the eyes (jaundice)
-dark urine
-fatigue
-nausea
-vomiting
-loss of appetite
-abdominal pain on the right side
-easily bruising
Seek medical attention immediatelyif you experience any of these symptoms.
Clots in the blood
Deep vein thrombosis (DVT) and pulmonary embolism
Votrient may cause clots in the veins, especially in the legs (deep vein thrombosis or DVT), which may travel to the lungs (pulmonary embolism). The signs and symptoms may include:
Microangiopathic thrombosis (MAT)
Votrient may cause clots in the blood in small blood vessels in the kidneys and brain, accompanied by a reduction in red blood cells and cells involved in blood clotting (microangiopathic thrombosis, MAT). The signs and symptoms may include:
Seek medical attention immediatelyif you experience any of these symptoms.Tumor lysis syndrome
Votrient may cause a rapid destruction of cancer cells, leading to tumor lysis syndrome, which in some people may be fatal. The symptoms may include irregular heartbeat, seizures, confusion, muscle cramps or spasms, or decreased urine output.Seek medical attention immediatelyif you experience any of these symptoms.
Infections
Infections that occur while taking Votrient may become serious. The symptoms of infections may include:
Seek medical attention immediatelyif you experience any of these symptoms.
Pneumonia
Votrient may cause, in rare cases, inflammation of the lungs (interstitial lung disease, pneumonitis), which in some people may be fatal. The symptoms include difficulty breathing or a cough that does not go away. Your doctor will monitor you for any lung problems while you are taking Votrient.
Seek medical attention immediatelyif you experience any of these symptoms.
Thyroid problems
Votrient may decrease the amount of thyroid hormone produced in your body. This may cause weight gain and fatigue. Your doctor will monitor your thyroid hormone levels while you are taking Votrient.
Inform your doctorif you notice significant weight gain or fatigue.
Blurred vision or vision changes
Votrient may cause the separation or tearing of the back of the eye (retinal detachment or tear). This may cause blurred vision or vision changes.
Inform your doctorif you notice any change in your vision.
Possible side effects (including possible serious side effects under the category of relevant frequency).
Very common side effects(may affect more than 1 in 10 people):
Inform your doctor or pharmacistif any of these side effects become problematic.
Very common side effects that may appear in your blood or urine tests:
Common side effects(may affect up to 1 in 10 people):
Inform your doctor or pharmacistif any of these side effects become problematic.
Common side effects that may appear in your blood or urine tests:
Rare side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Unknown frequency(cannot be estimated from available data):
Reporting of side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect that does not appear in this leaflet.You can also report them directly through theAppendix V. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the bottle and on the carton afterEXP andCAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.
Composition of Votrient
Each Votrient 200 mg film-coated tablet contains 200 mg of pazopanib.
Each Votrient 400 mg film-coated tablet contains 400 mg of pazopanib.
Appearance of the product and contents of the pack
Votrient 200 mg film-coated tablets are capsule-shaped, pink, marked with “GS JT” on one side. They are supplied in bottles of 30 or 90 tablets.
Votrient 400 mg film-coated tablets are capsule-shaped, white, marked with “GS UHL” on one side. They are supplied in bottles of 30 or 60 tablets.
Only some pack sizes may be marketed.
Marketing authorisation holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Responsible manufacturer
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana
Slovenia
Novartis Pharmaceutical Manufacturing LLC
Verovškova ulica 57
1000 Ljubljana
Slovenia
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Germany
Glaxo Wellcome, S.A.
Avda.Extremadura, 3
09400 Aranda de Duero, Burgos
Spain
Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
For further information about this medicinal product, please consult the representative of the marketing authorisation holder in your country:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +322 246 16 11 | |
Ceská republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +3562122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 88 04 52 555 |
Eesti SIA Novartis Baltics Eesti filiaal Tel: +37266 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Ελλ?δα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel: +358(0)10 6133 200 |
Κ?προς Novartis Pharma Services Inc. Τηλ: +357 22 690 690 | Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvija SIA Novartis Baltics Tel: +371 67 887 070 |
Last update of this leaflet:
Other sources of information
The detailed information on this medicinal product is available on the website of the European Medicines Agencyhttp://www.ema.europa.eu/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.